Clinical Trials Directory

Trials / Completed

CompletedNCT04594434

Eye Movement Desensitization and Reprocessing (EMDR) in Complex Psychotrauma

Efficiency of the Use of Benevolent Memories in the EMDR Protocol in Complex Psychotrauma (Benevolence Study)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
49 (actual)
Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study wants to demonstrate the effectiveness of combining a positive memory with "recommended" therapy based on EMDR in reducing the disturbance that patients with complex psychotrauma may experience. The positive memory will be called "benevolent memory" (SB) or "less worse memory" (SMP).

Detailed description

This is an interventional study, prospective, exploratory, comparative, randomized, controlled versus reference treatment protocol, open. Patients will be seen 16 times for the purposes of the study. They will be hospitalized during therapy. Discharge from hospitalization occurs during follow-up depending on the patient's condition. They will be evaluated over a period of 4 to 6 weeks between the start (Day 0 = Week 1) and the end of treatment (visit week 12). These visits will coincide with treatment sessions with the EMDR ± SB / SMP protocol, as part of the support of their complex psychotrauma. At the end of treatment, the patient will be evaluated during follow-up visits at Month 1, Month 3 and Month 6.

Conditions

Interventions

TypeNameDescription
OTHERScale SUDSubjective Units of Distress Scale ou Subjective Units of Disturbance Scale is a scale of subjective appreciation of emotions
OTHERVOC scaleThe VOC (Validity Of Cognition) scale is a scale of value given to cognition.
OTHERDES II scaleThe Dissociative Experiences Scale (DES), which is translated as the Dissociative Experiences Scale, is a self-questionnaire to assess the frequency of various dissociative symptoms in the patient's daily life.

Timeline

Start date
2020-12-12
Primary completion
2022-07-26
Completion
2022-07-26
First posted
2020-10-20
Last updated
2022-08-17

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04594434. Inclusion in this directory is not an endorsement.